BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20640899)

  • 21. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of different mathematical models and different b-value ranges of diffusion-weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm2.
    Feng Z; Min X; Margolis DJ; Duan C; Chen Y; Sah VK; Chaudhary N; Li B; Ke Z; Zhang P; Wang L
    PLoS One; 2017; 12(2):e0172127. PubMed ID: 28199367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relaxation along fictitious field, diffusion-weighted imaging, and T2 mapping of prostate cancer: Prediction of cancer aggressiveness.
    Jambor I; Pesola M; Merisaari H; Taimen P; Boström PJ; Liimatainen T; Aronen HJ
    Magn Reson Med; 2016 May; 75(5):2130-40. PubMed ID: 26094849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
    Haider MA; van der Kwast TH; Tanguay J; Evans AJ; Hashmi AT; Lockwood G; Trachtenberg J
    AJR Am J Roentgenol; 2007 Aug; 189(2):323-8. PubMed ID: 17646457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diffusion-weighted imaging for prostate cancer localization: comparison of apparent diffusion coefficient values in cancerous and non-cancerous tissues, and the Gleason score of the radical prostatectomy specimens].
    Kobayashi H; Kitamura K; Mizukami S; Hanazawa K; Sakamoto Y
    Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):489-95. PubMed ID: 23819360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network.
    Aldoj N; Lukas S; Dewey M; Penzkofer T
    Eur Radiol; 2020 Feb; 30(2):1243-1253. PubMed ID: 31468158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis.
    Wu LM; Xu JR; Ye YQ; Lu Q; Hu JN
    AJR Am J Roentgenol; 2012 Jul; 199(1):103-10. PubMed ID: 22733900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imaging.
    Kwak JT; Xu S; Wood BJ; Turkbey B; Choyke PL; Pinto PA; Wang S; Summers RM
    Med Phys; 2015 May; 42(5):2368-78. PubMed ID: 25979032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the most effective tool for detecting prostate cancer using a standard MR scanner?
    Osugi K; Tanimoto A; Nakashima J; Shinoda K; Hashiguchi A; Oya M; Jinzaki M; Kuribayashi S
    Magn Reson Med Sci; 2013 Dec; 12(4):271-80. PubMed ID: 24172787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion of high B-value diffusion-weighted and T2-weighted MR images increases sensitivity for identification of extraprostatic disease in prostate cancer.
    Colvin SD; Cason DE; Galgano SJ; Triche BL; Gordetsky J; Rais-Bahrami S; Porter KK
    Clin Imaging; 2020 Dec; 68():202-209. PubMed ID: 32892105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
    Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
    Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
    Kim CK; Park BK; Kim B
    AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis.
    Ueno Y; Takahashi S; Kitajima K; Kimura T; Aoki I; Kawakami F; Miyake H; Ohno Y; Sugimura K
    Eur Radiol; 2013 Dec; 23(12):3509-16. PubMed ID: 23881300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
    Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI.
    Wu LM; Chen XX; Xu JR; Zhang XF; Suo ST; Yao QY; Fan Y; Hu J
    Acad Radiol; 2013 Aug; 20(8):939-46. PubMed ID: 23746384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of three-dimensional T2-weighted turbo spin-echo imaging with tissue-specific variable refocusing flip angle for 3-T magnetic resonance imaging of prostate cancer: comparison with conventional two- and three-dimensional T2-weighted turbo spin-echo imaging.
    Tanaka U; Ueno Y; Morinaga Y; Miyake H; Kyotani K; Ueda Y; Kitajima K; Sofue K; Suenaga Y; Sugimura K; Takahashi S
    Jpn J Radiol; 2017 Dec; 35(12):707-717. PubMed ID: 28983811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.
    Agarwal HK; Mertan FV; Sankineni S; Bernardo M; Senegas J; Keupp J; Daar D; Merino M; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    J Magn Reson Imaging; 2017 Jan; 45(1):125-131. PubMed ID: 27383502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.